Diagnostic Testing During a Pandemic by Pharmaceutical Commerce Magazine published on 2021-12-01T16:42:10Z Pouria Sanae, CEO of ixlayer, a technology company, explains the obstacles surrounding the distribution of remote lab tests pre-, during and post-pandemic, the shift to at-home Covid screenings, the logistical challenges in collaborating with different US regions, and the concept of the “pre-patient” model for preventative care. Genre Business